Cas no 24516-39-0 (Cholesteryl Erucate)
Cholesteryl Erucate is a cholesterol derivative formed by the esterification of cholesterol with erucic acid. This compound is characterized by its long hydrophobic tail, which enhances lipid solubility and stability in nonpolar environments. It is commonly utilized in lipid-based formulations, such as liposomes and emulsions, where it contributes to membrane fluidity and structural integrity. Its biocompatibility makes it suitable for pharmaceutical and cosmetic applications, particularly in drug delivery systems requiring controlled release. Cholesteryl Erucate’s high melting point and resistance to oxidation further ensure prolonged shelf life in formulations. Its unique properties make it a valuable component in advanced lipid research and industrial applications.
Cholesteryl Erucate structure
Product Name:Cholesteryl Erucate
CAS No:24516-39-0
MF:C49H86O2
MW:707.205955982208
CID:265361
PubChem ID:24892949
Update Time:2025-10-24
Cholesteryl Erucate Chemical and Physical Properties
Names and Identifiers
-
- Cholest-5-en-3-ol (3b)-, 3-(13Z)-13-docosenoate
- 5-CHOLESTEN-3B-OL 3-ERUCATE
- Cholesteryl erucate
- 3BETA-HYDROXY-5-CHOLESTENE 3-ERUCATE
- 5-CHOLESTEN-3BETA-OL 3-ERUCATE
- cholesterol erucate
- CHOLESTERYL CIS-13-DOCOSENOATE
- Cholesterylerucat
- Einecs 246-292-5
- Eruaeure-cholesterylester
- 3β-Hydroxy-5-cholestene 3-erucate
- 5-Cholesten-3β-ol 3-erucate
- cholest-5-en-3b-yl (13Z-docosenoate)
- MFCD00037704
- Cholest-5-en-3b-yl (13Z-docosenoic acid)
- NS00050619
- 24516-39-0
- cholesteryl (13Z)-docosenoate
- LMST01020025
- Cholest-5-en-3-ol(3b)-,3-(13Z)-13-docosenoate
- J-015550
- CE(22:1)
- Cholest-5-en-3-ol (3beta)-, 3-(13Z)-13-docosenoate
- CHEBI:169898
- cholesterol (13Z)-docosenoate
- AKOS032953553
- [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-docos-13-enoate
- Cholesteryl erucate, >=95%
- 22:1 Cholesteryl ester
- CS-0136086
- [(3S, 8S, 9S, 10R, 13R, 14S, 17R)-10, 13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2, 3, 4, 7, 8, 9, 11, 12, 14, 15, 16, 17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (Z)-docos-13-enoate
- HY-133962
- Cholest-5-en-3-ol (3beta)-, (13Z)-13-docosenoate
- SQHUGNAFKZZXOT-QXAJUEOOSA-N
- G77523
- Cholesteryl Erucate
-
- MDL： MFCD00037704
- Inchi： 1S/C49H86O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22-23-24-25-29-47(50)51-42-34-36-48(5)41(38-42)30-31-43-45-33-32-44(40(4)28-26-27-39(2)3)49(45,6)37-35-46(43)48/h14-15,30,39-40,42-46H,7-13,16-29,31-38H2,1-6H3/b15-14-/t40-,42+,43+,44-,45+,46+,48+,49-/m1/s1
- InChI Key： SQHUGNAFKZZXOT-QXAJUEOOSA-N
- SMILES： O(C(CCCCCCCCCCC/C=C\CCCCCCCC)=O)[C@H]1CC[C@@]2(C)C(C1)=CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]21
Computed Properties
- Exact Mass: 706.66300
- Monoisotopic Mass: 706.663
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 51
- Rotatable Bond Count: 26
- Complexity: 1040
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 8
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 1
- Topological Polar Surface Area: 26.3A^2
- XLogP3: 18.8
Experimental Properties
- Density: 0.95
- Boiling Point: 710.2°Cat760mmHg
- Flash Point: 384.6°C
- Refractive Index: 1.509
- PSA: 26.30000
- LogP: 15.53750
- Vapor Pressure: 0.0±2.3 mmHg at 25°C
Cholesteryl Erucate Security Information
- Signal Word：warning
- Hazard Statement： H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement： P264+P280+P305+P351+P338+P337+P313
- Hazardous Material transportation number：NONH for all modes of transport
- WGK Germany：3
- Safety Instruction： H303+H313+H333
- Storage Condition：?20°C
Cholesteryl Erucate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | C432560-100mg |
Cholesteryl Erucate |
24516-39-0 | 100mg |
$ 58.00 | 2023-09-08 | ||
| TRC | C432560-250mg |
Cholesteryl Erucate |
24516-39-0 | 250mg |
$ 75.00 | 2023-09-08 | ||
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci64326-50mg |
Cholesteryl Erucate |
24516-39-0 | 98% | 50mg |
￥377.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci64326-100mg |
Cholesteryl Erucate |
24516-39-0 | 98% | 100mg |
￥574.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci64326-250mg |
Cholesteryl Erucate |
24516-39-0 | 98% | 250mg |
￥1241.00 | 2023-09-09 | |
| WU HAN AN JIE KAI Biomedical Technology Co., Ltd. | ajci64326-500mg |
Cholesteryl Erucate |
24516-39-0 | 98% | 500mg |
￥2217.00 | 2023-09-09 | |
| MedChemExpress | HY-133962-50mg |
Cholesteryl erucate |
24516-39-0 | 50mg |
￥666 | 2024-05-22 | ||
| A2B Chem LLC | AB24727-50mg |
Cholest-5-en-3-ol (3β)-, 3-(13Z)-13-docosenoate |
24516-39-0 | ≥98% | 50mg |
$29.00 | 2024-04-20 | |
| A2B Chem LLC | AB24727-100mg |
Cholest-5-en-3-ol (3β)-, 3-(13Z)-13-docosenoate |
24516-39-0 | ≥98% | 100mg |
$44.00 | 2024-04-20 | |
| A2B Chem LLC | AB24727-250mg |
Cholest-5-en-3-ol (3β)-, 3-(13Z)-13-docosenoate |
24516-39-0 | ≥98% | 250mg |
$100.00 | 2024-04-20 |
Cholesteryl Erucate Related Literature
-
Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
-
Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
-
Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
-
Priyambada Nayak,Tanmaya Badapanda,Anil Kumar Singh,Simanchalo Panigrahi RSC Adv., 2017,7, 16319-16331
-
Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
24516-39-0 (Cholesteryl Erucate) Related Products
- 303-43-5(Cholesteryl oleate)
- 604-33-1(Cholesterol Linoleate)
- 601-34-3(Cholesteryl palmitate)
- 521-13-1(Cholesteryl N-Butyrate)
- 1182-42-9(Cholesterol Caprylate)
- 1908-11-8(Cholesterol Laurate)
- 1989-52-2(Cholesterol myristate)
- 633-31-8([(8S,9R,10R,13R,14S)-10,13-Dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] propanoate)
- 604-35-3(Cholesterol 3-Acetate)
- 853-23-6(dehydroisoandrosterone 3-acetate)
Recommended suppliers
Hangzhou Cedareal Technology Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
PRIBOLAB PTE.LTD
Gold Member
Audited Supplier
CN Supplier
Reagent
SunaTech Inc.
Gold Member
Audited Supplier
CN Supplier
Reagent
上海帛亦醫(yī)藥科技有限公司
Gold Member
Audited Supplier
CN Supplier
Reagent
Zhengzhou Baoyu Pharmaceutical Co., Ltd.
Gold Member
Audited Supplier
CN Supplier
Bulk
